federal_register: 2019-23335

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2019-23335 Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry Notice The Food and Drug Administration (FDA or Agency) is announcing the availability of a revised draft guidance for FDA staff and industry entitled "Drug Products Labeled as Homeopathic." The revised draft guidance, like the original version, describes how FDA intends to prioritize enforcement and regulatory action with regard to drug products, including biological products, labeled as homeopathic and marketed in the United States without the required FDA approval that potentially pose higher risk to public health. In response to comments received, we have revised the draft guidance and are reissuing it in draft form to enable the public to review and comment before it is finalized. 2019-10-25 2019 10 https://www.federalregister.gov/documents/2019/10/25/2019-23335/drug-products-labeled-as-homeopathic-draft-guidance-for-food-and-drug-administration-staff-and https://www.govinfo.gov/content/pkg/FR-2019-10-25/pdf/2019-23335.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA or Agency) is announcing the availability of a revised draft guidance for FDA staff and industry entitled "Drug Products Labeled as Homeopathic." The revised draft guidance, like the original version, describes how...  

Links from other tables